NeuroVoices: Cathleen Lutz, MD, on the Potential of Stathmin-2 as an ALS-Specific Biomarker.

M Meglio - Neurology Live, 2023 - go.gale.com
Amyotrophic lateral sclerosis (ALS), a neuromuscular disease characterized by selective
degeneration of upper and lower motor neurons, is currently lacking validating disease …
相关文章

NeuroVoices: Cathleen Lutz, PhD, on the Potential of Stathmin-2 as an ALS-Specific Biomarker.

M Meglio - Neurology Live, 2023 - go.gale.com
Amyotrophic lateral sclerosis (ALS), a neuromuscular disease characterized by selective
degeneration of upper and lower motor neurons, is currently lacking validating disease …